SCHEMBL24310158

SCHEMBL24310158

Cc1ccccc1-c1nc(NSc2cnn(C)c2)nc(Oc2ccc(N3CCN(C)CC3)cc2)c1C(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K1 Q92918 1/20 0.37
▸ PDE2A O00408 1/20 0.37
▸ PDE10A Q9Y233 1/20 0.37
▸ ITK Q08881 1/20 0.35
▸ CTSC P53634 2/20 0.34
▸ IGF1R P08069 1/20 0.34
▸ HRH4 Q9H3N8 3/20 0.34
▸ TTK P33981 1/20 0.34
▸ MAP3K7 O43318 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ MAP2K1 Q02750 1/20 0.33
▸ JAK2 O60674 1/20 0.33
▸ JAK1 P23458 1/20 0.33
▸ TYK2 P29597 1/20 0.33
▸ STAT3 P40763 1/20 0.33
▸ JAK3 P52333 1/20 0.33
▸ TNK2 Q07912 2/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ CCNK O75909 1/20 0.33
▸ CCNA2 P20248 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310171 0.94 CTSC (0.36) MAP4K1PDE2APDE10AITKCTSC
SCHEMBL24310153 0.92 CTSC (0.36) MAP4K1CTSCIGF1RHRH4JAK2
SCHEMBL24310424 0.89 PDE2A (0.41) MAP4K1PDE2APDE10AITKCTSC
SCHEMBL24310428 0.89 MAP4K1 (0.38) MAP4K1PDE2APDE10AITKCTSC
SCHEMBL24309551 0.89 FYN (0.32) TNK2
SCHEMBL24309719 0.88 MAP4K1 (0.37) MAP4K1PDE2APDE10AITKCTSC
SCHEMBL24309882 0.88 MAP4K1 (0.37) MAP4K1PDE2APDE10AITKCTSC
SCHEMBL24309386 0.87 JAK2 (0.37) MAP4K1PDE2APDE10AITKCTSC
SCHEMBL24309392 0.87 BRD4 (0.37) MAP4K1PDE2APDE10AITKCTSC
SCHEMBL24310590 0.84 IGF1R (0.31) IGF1RJAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback